AKT1 and cancer: Based on growing evidence showing that the three AKT isoforms play differing roles in the progression of some cancers, including PC [38, 39], the differing disease phenotypes in our two transgenic models could be explained by the differential activation and preferential dependence on specific AKT isoforms.